facebook
eISSN: 2084-9893
ISSN: 0033-2526
Dermatology Review/Przegląd Dermatologiczny
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
6/2018
vol. 105
 
Share:
Share:
abstract:
Case report

Bullous skin lesion reaction as an example of an adverse effect of a preparation containing 0.1% octenidine dihydrochloride and 2% phenoxyethanol (Octenisept®)

Agnieszka Hołdrowicz
,
Joanna Narbutt
,
Cezary Pałczyński
,
Izabela Kupryś-Lipińska
,
Aleksandra Lesiak

Dermatol Rev/Przegl Dermatol 2018, 105, 753–760
Online publish date: 2019/01/04
View full text Get citation
 
PlumX metrics:
Introduction
Octenisept® is an antiseptic solution which is intended to be applied on the skin, mucous membranes and wounds.

Objective
To present a case study of a bullous skin lesions, which occurred in a 4-year-old girl after Octenisept® application, and to highlight various possible side effects of this preparation.

Case report
In a 4-year-old girl Octenisept® was applied preventively three times at intervals of 12 hours on an epidermal abrasion. Erythema and hydropic papules emerged 6–8 hours after application and were followed by vesicles and bullae 8 hours later. In spite of the topical treatment with glucocorticoids and an antibiotic, the lesions persisted for several weeks.

Conclusions
Taking into consideration the wide usage of Octenisept® in many fields of medicine, there is a need to conduct further research on the allergic potential and toxicity of this product.

keywords:

adverse effects, Octenisept®, bullous skin lesion reaction



Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.